<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
On Monday, Merck & Co Inc. (NYSE:MRK) shares plunged by more than 5% amid concerns about the efficacy of its molnupiravir drug as a treatment for covid-19. The pill is poised for authorisation by the US Food and Drug Administration (FDA), but analysts fear its efficacy could hamper use.
...read full article on Invezz
